Citations (103)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Olga Scharkoi, Roland Becker, Susanne Esslinger, Marcus Weber & Irene Nehls. (2015) Predicting sites of cytochrome P450-mediated hydroxylation applied to CYP3A4 and hexabromocyclododecane. Molecular Simulation 41:7, pages 538-546.
Read now
Read now
Patrik Rydberg, Flemming Steen Jørgensen & Lars Olsen. (2014) Use of density functional theory in drug metabolism studies. Expert Opinion on Drug Metabolism & Toxicology 10:2, pages 215-227.
Read now
Read now
James Matthew Hutzler, Ronald Scott Obach, Deepak Dalvie & Michael A Zientek. (2013) Strategies for a comprehensive understanding of metabolism by aldehyde oxidase. Expert Opinion on Drug Metabolism & Toxicology 9:2, pages 153-168.
Read now
Read now
Peter Ballard, Patrick Brassil, Khanh H. Bui, Hugues Dolgos, Carl Petersson, Anders Tunek & Peter J. H. Webborn. (2012) The right compound in the right assay at the right time: an integrated discovery DMPK strategy. Drug Metabolism Reviews 44:3, pages 224-252.
Read now
Read now
Nitish Kumar Mishra. (2011) Computational modeling of P450s for toxicity prediction. Expert Opinion on Drug Metabolism & Toxicology 7:10, pages 1211-1231.
Read now
Read now
Ákos Tarcsay & György M Keserű. (2011)
In silico site of metabolism prediction of cytochrome P450-mediated biotransformations. Expert Opinion on Drug Metabolism & Toxicology 7:3, pages 299-312.
Read now
Read now
Roy J Vaz, Ismael Zamora, Yi Li, Stephan Reiling, Jian Shen & Gabriele Cruciani. (2010) The challenges of in silico contributions to drug metabolism in lead optimization. Expert Opinion on Drug Metabolism & Toxicology 6:7, pages 851-861.
Read now
Read now
Anne Baumann & Uwe Karst. (2010) Online electrochemistry/mass spectrometry in drug metabolism studies: principles and applications. Expert Opinion on Drug Metabolism & Toxicology 6:6, pages 715-731.
Read now
Read now
David FV Lewis & Yuko Ito. (2010) Human CYPs involved in drug metabolism: structures, substrates and binding affinities. Expert Opinion on Drug Metabolism & Toxicology 6:6, pages 661-674.
Read now
Read now
Olavi Pelkonen, Ari Tolonen, Timo Korjamo, Miia Turpeinen & Hannu Raunio. (2009) From Known Knowns to Known Unknowns: Predicting in Vivo Drug Metabolites. Bioanalysis 1:2, pages 393-414.
Read now
Read now
David FV Lewis & Yuko Ito. (2008) Human cytochromes P450 in the metabolism of drugs: new molecular models of enzyme–substrate interactions. Expert Opinion on Drug Metabolism & Toxicology 4:9, pages 1181-1186.
Read now
Read now
Eva Stjernschantz, Nico PE Vermeulen & Chris Oostenbrink. (2008) Computational prediction of drug binding and rationalisation of selectivity towards cytochromes P450. Expert Opinion on Drug Metabolism & Toxicology 4:5, pages 513-527.
Read now
Read now
Articles from other publishers (91)
Jiamin Chang, Xiaoyu Fan & Boxue Tian. (2024) DeepP450: Predicting Human P450 Activities of Small Molecules by Integrating Pretrained Protein Language Model and Molecular Representation. Journal of Chemical Information and Modeling 64:8, pages 3149-3160.
Crossref
Crossref
Yanjun Feng, Changda Gong, Jieyu Zhu, Guixia Liu, Yun Tang & Weihua Li. (2023) Prediction of Sites of Metabolism of CYP3A4 Substrates Utilizing Docking-Derived Geometric Features. Journal of Chemical Information and Modeling 63:13, pages 4158-4169.
Crossref
Crossref
F. Peter Guengerich. 2022. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary
1
47
.
Jonathan D Tyzack. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
769
791
.
Alan Talevi. 2022. The ADME Encyclopedia. The ADME Encyclopedia
1073
1081
.
Mael Conan, Nathalie Théret, Sophie Langouet & Anne Siegel. (2021) Constructing xenobiotic maps of metabolism to predict enzymes catalyzing metabolites capable of binding to DNA. BMC Bioinformatics 22:1.
Crossref
Crossref
Zongzhe He, Zhen Wang, Beibei Gao, Shiling Liu, Xuejun Zhao, Haiyan Shi & Minghua Wang. (2021) Stereostructure-activity mechanism of cyproconazole by cytochrome P450 in rat liver microsomes: A combined experimental and computational study. Journal of Hazardous Materials 416, pages 125764.
Crossref
Crossref
Alan Talevi. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
9
.
. 2020. ANSI/AAMI/ISO 10993-16:2017; Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables. ANSI/AAMI/ISO 10993-16:2017; Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables.
Agostino Bruno, Gabriele Costantino, Luca Sartori & Marco Radi. (2019) The In Silico Drug Discovery Toolbox: Applications in Lead Discovery and Optimization. Current Medicinal Chemistry 26:21, pages 3838-3873.
Crossref
Crossref
Xingxing Diao & Marilyn A. Huestis. (2019) New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites. Frontiers in Chemistry 7.
Crossref
Crossref
Surovi Saikia, Manobjyoti Bordoloi, Rajeev Sarmah & Bhaskor Kolita. (2018) Antiviral compound screening, peptide designing, and protein network construction of influenza a virus (strain a/Puerto Rico/8/1934 H1N1). Drug Development Research 80:1, pages 106-124.
Crossref
Crossref
Xiongyi Huang & John T. Groves. (2017) Oxygen Activation and Radical Transformations in Heme Proteins and Metalloporphyrins. Chemical Reviews 118:5, pages 2491-2553.
Crossref
Crossref
Jiajia Meng, Shiliang Li, Xiaofeng Liu, Mingyue Zheng & Honglin Li. (2017) RD-Metabolizer: an integrated and reaction types extensive approach to predict metabolic sites and metabolites of drug-like molecules. Chemistry Central Journal 11:1.
Crossref
Crossref
X Diao & MA Huestis. (2016) Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites. Clinical Pharmacology & Therapeutics 101:2, pages 239-253.
Crossref
Crossref
Huirong Fan, Zhanxing Hu, Ruixing Li, Shiqi Dong, Yuan Gu, Ting Liu, Duanyun Si, Guangyi Liang & Changxiao Liu. (2017) Metabolite identification of bentysrepinine (Y101), a novel anti-HBV agent in rats using a five-step strategy based on a combined workflow with two different platforms of liquid chromatography–tandem mass spectrometry. Journal of Chromatography B 1040, pages 118-128.
Crossref
Crossref
Vaibhav A. DixitShirish Deshpande. (2016) Advances in Computational Prediction of Regioselective and Isoform-Specific Drug Metabolism Catalyzed by CYP450s.. ChemistrySelect 1:20, pages 6571-6597.
Crossref
Crossref
Alexander L. Perryman, Thomas P. Stratton, Sean Ekins & Joel S. Freundlich. (2015) Predicting Mouse Liver Microsomal Stability with “Pruned” Machine Learning Models and Public Data. Pharmaceutical Research 33:2, pages 433-449.
Crossref
Crossref
Junhao Li, Jinya Cai, Haixia Su, Hanwen Du, Juan Zhang, Shihui Ding, Guixia Liu, Yun Tang & Weihua Li. (2016) Effects of protein flexibility and active site water molecules on the prediction of sites of metabolism for cytochrome P450 2C19 substrates. Molecular BioSystems 12:3, pages 868-878.
Crossref
Crossref
Yufeng J. Tseng, Bo-Han Su, Ming-Tsung Hsu & Olivia A. Lin. 2016. Frontiers in Molecular Design and Chemical Information Science - Herman Skolnik Award Symposium 2015: Jürgen Bajorath. Frontiers in Molecular Design and Chemical Information Science - Herman Skolnik Award Symposium 2015: Jürgen Bajorath
283
329
.
Lars Olsen, Flemming Steen Jørgensen & Chris Oostenbrink. 2015. New Horizons in Predictive Drug Metabolism and Pharmacokinetics. New Horizons in Predictive Drug Metabolism and Pharmacokinetics
66
78
.
Alexander V. LyubimovRodolpho C. Braga, Vinicius M. Alves, Flavia C. Silva & Carolina H. Andrade. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
28
.
Ulrik Jurva & Lars Weidolf. (2015) Electrochemical generation of drug metabolites with applications in drug discovery and development. TrAC Trends in Analytical Chemistry 70, pages 92-99.
Crossref
Crossref
Lars Olsen, Chris Oostenbrink & Flemming Steen Jørgensen. (2015) Prediction of cytochrome P450 mediated metabolism. Advanced Drug Delivery Reviews 86, pages 61-71.
Crossref
Crossref
M. B. Shah, P. R. Wilderman, J. Liu, H.-H. Jang, Q. Zhang, C. D. Stout & J. R. Halpert. (2015) Structural and Biophysical Characterization of Human Cytochromes P450 2B6 and 2A6 Bound to Volatile Hydrocarbons: Analysis and Comparison. Molecular Pharmacology 87:4, pages 649-659.
Crossref
Crossref
Goutam Mukherjee, Pancham Lal Gupta & B. Jayaram. (2015) Predicting the binding modes and sites of metabolism of xenobiotics. Molecular BioSystems 11:7, pages 1914-1924.
Crossref
Crossref
Paul R. Ortiz de Montellano. 2015. Cytochrome P450. Cytochrome P450
111
176
.
Preeti Pragyan, Siddharth S. Kesharwani, Prajwal P. Nandekar, Vijay Rathod & Abhay T. Sangamwar. (2014) Predicting drug metabolism by CYP1A1, CYP1A2, and CYP1B1: insights from MetaSite, molecular docking and quantum chemical calculations. Molecular Diversity 18:4, pages 865-878.
Crossref
Crossref
Patrik Rydberg. 2014. Drug Metabolism Prediction. Drug Metabolism Prediction
265
292
.
Chris Oostenbrink. 2014. Drug Metabolism Prediction. Drug Metabolism Prediction
243
264
.
Frederick Peter Guengerich. 2014. Drug Metabolism Prediction. Drug Metabolism Prediction
199
220
.
Andrew G. Leach & Nathan J. Kidley. 2014. Drug Metabolism Prediction. Drug Metabolism Prediction
103
132
.
Bernard Testa. 2014. Drug Metabolism Prediction. Drug Metabolism Prediction
1
26
.
Gisela Br?nd?n, Tove Sj?gren, Volker Schnecke & Yafeng Xue. (2014) Structure-based ligand design to overcome CYP inhibition in drug discovery projects. Drug Discovery Today 19:7, pages 905-911.
Crossref
Crossref
Sean Ekins. (2014) Progress in computational toxicology. Journal of Pharmacological and Toxicological Methods 69:2, pages 115-140.
Crossref
Crossref
Anna Artese, Simon Cross, Giosuè Costa, Simona Distinto, Lucia Parrotta, Stefano Alcaro, Francesco Ortuso & Gabriele Cruciani. (2013) Molecular interaction fields in drug discovery: recent advances and future perspectives. WIREs Computational Molecular Science 3:6, pages 594-613.
Crossref
Crossref
Jonathan D. Tyzack, Mark J. Williamson, Rubben Torella & Robert C. Glen. (2013) Prediction of Cytochrome P450 Xenobiotic Metabolism: Tethered Docking and Reactivity Derived from Ligand Molecular Orbital Analysis. Journal of Chemical Information and Modeling 53:6, pages 1294-1305.
Crossref
Crossref
Gabriele Cruciani, Massimo Baroni, Paolo Benedetti, Laura Goracci & Cosimo Gianluca Fortuna. (2013) Exposition and reactivity optimization to predict sites of metabolism in chemicals. Drug Discovery Today: Technologies 10:1, pages e155-e165.
Crossref
Crossref
Andrew G. Leach. 2015. Tactics in Contemporary Drug Design. Tactics in Contemporary Drug Design
107
158
.
Kiumars Shahrokh, Thomas E. CheathamIIIIII & Garold S. Yost. (2012) Conformational dynamics of CYP3A4 demonstrate the important role of Arg212 coupled with the opening of ingress, egress and solvent channels to dehydrogenation of 4-hydroxy-tamoxifen. Biochimica et Biophysica Acta (BBA) - General Subjects 1820:10, pages 1605-1617.
Crossref
Crossref
Valérie Campagna-Slater, Joshua Pottel, Eric Therrien, Louis-David Cantin & Nicolas Moitessier. (2012) Development of a Computational Tool to Rival Experts in the Prediction of Sites of Metabolism of Xenobiotics by P450s. Journal of Chemical Information and Modeling 52:9, pages 2471-2483.
Crossref
Crossref
Honglin Li, Mingyue Zheng, Xiaomin Luo, Weiliang Zhu & Hualiang Jiang. 2012. Chemical Biology. Chemical Biology
23
40
.
Deepak Dalvie, Hao Sun, Cathie Xiang, Qiyue Hu, Ying Jiang & Ping Kang. (2012) Effect of Structural Variation on Aldehyde Oxidase-Catalyzed Oxidation of Zoniporide. Drug Metabolism and Disposition 40:8, pages 1575-1587.
Crossref
Crossref
Patrik Rydberg & Lars Olsen. (2012) Predicting Drug Metabolism by Cytochrome P450 2C9: Comparison with the 2D6 and 3A4 Isoforms. ChemMedChem 7:7, pages 1202-1209.
Crossref
Crossref
Ruifeng Liu, Jin Liu, Greg Tawa & Anders Wallqvist. (2012) 2D SMARTCyp Reactivity-Based Site of Metabolism Prediction for Major Drug-Metabolizing Cytochrome P450 Enzymes. Journal of Chemical Information and Modeling 52:6, pages 1698-1712.
Crossref
Crossref
F. Peter Guengerich. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
27
66
.
Johannes Kirchmair, Mark J. Williamson, Jonathan D. Tyzack, Lu Tan, Peter J. Bond, Andreas Bender & Robert C. Glen. (2012) Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms. Journal of Chemical Information and Modeling 52:3, pages 617-648.
Crossref
Crossref
Brooks McPhail, Yunfeng Tie, Huixiao Hong, Bruce A. Pearce, Laura K. Schnackenberg, Weigong Ge, Luis G. ValerioJr.Jr., James C. Fuscoe, Weida Tong, Dan A. Buzatu, Jon G. Wilkes, Bruce A. Fowler, Eugene Demchuk & Richard D. Beger. (2012) Modeling Chemical Interaction Profiles: I. Spectral Data-Activity Relationship and Structure-Activity Relationship Models for Inhibitors and Non-inhibitors of Cytochrome P450 CYP3A4 and CYP2D6 Isozymes. Molecules 17:3, pages 3383-3406.
Crossref
Crossref
Alexander V. LyubimovF. Peter Guengerich. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
23
.
Kiumars Shahrokh, Anita Orendt, Garold S. Yost & Thomas E. CheathamIIIIII. (2011) Quantum mechanically derived AMBER‐compatible heme parameters for various states of the cytochrome P450 catalytic cycle. Journal of Computational Chemistry 33:2, pages 119-133.
Crossref
Crossref
Gautier Moroy, Virginie Y. Martiny, Philippe Vayer, Bruno O. Villoutreix & Maria A. Miteva. (2012) Toward in silico structure-based ADMET prediction in drug discovery. Drug Discovery Today 17:1-2, pages 44-55.
Crossref
Crossref
Antony J. Williams, Sean Ekins, Ola Spjuth & Egon L. Willighagen. 2012. Computational Toxicology. Computational Toxicology
221
241
.
Jianing Li, Severin T. Schneebeli, Joseph Bylund, Ramy Farid & Richard A. Friesner. (2011) IDSite: An Accurate Approach to Predict P450-Mediated Drug Metabolism. Journal of Chemical Theory and Computation 7:11, pages 3829-3845.
Crossref
Crossref
H. T'jollyn, K. Boussery, R. J. Mortishire-Smith, K. Coe, B. De Boeck, J. F. Van Bocxlaer & G. Mannens. (2011) Evaluation of Three State-of-the-Art Metabolite Prediction Software Packages (Meteor, MetaSite, and StarDrop) through Independent and Synergistic Use. Drug Metabolism and Disposition 39:11, pages 2066-2075.
Crossref
Crossref
Matthew L. Danielson, Prashant V. Desai, Michael A. Mohutsky, Steven A. Wrighton & Markus A. Lill. (2011) Potentially increasing the metabolic stability of drug candidates via computational site of metabolism prediction by CYP2C9: The utility of incorporating protein flexibility via an ensemble of structures. European Journal of Medicinal Chemistry 46:9, pages 3953-3963.
Crossref
Crossref
Olavi Pelkonen, Miia Turpeinen & Hannu Raunio. (2011) In Vivo-In Vitro-In Silico Pharmacokinetic Modelling in Drug Development. Clinical Pharmacokinetics 50:8, pages 483-491.
Crossref
Crossref
Vaibhav A. Dixit & Prasad V. Bharatam. (2011) Toxic Metabolite Formation from Troglitazone (TGZ): New Insights from a DFT Study. Chemical Research in Toxicology 24:7, pages 1113-1122.
Crossref
Crossref
Carolina Horta Andrade, Lenis Medeiros de Freitas & Valéria de Oliveira. (2011) Twenty-six years of HIV science: an overview of anti-HIV drugs metabolism. Brazilian Journal of Pharmaceutical Sciences 47:2, pages 209-230.
Crossref
Crossref
Friederike Stoll, Andreas H. Göller & Alexander Hillisch. (2011) Utility of protein structures in overcoming ADMET-related issues of drug-like compounds. Drug Discovery Today 16:11-12, pages 530-538.
Crossref
Crossref
Patrick McCarren, Gregory R. Bebernitz, Peter Gedeck, Susanne Glowienke, Melissa S. Grondine, Louise C. Kirman, Jacob Klickstein, Herbert F. Schuster & Lewis Whitehead. (2011) Avoidance of the Ames test liability for aryl–amines via computation. Bioorganic & Medicinal Chemistry 19:10, pages 3173-3182.
Crossref
Crossref
Arthur N. Mayeno, Jonathan L. Robinson & Brad Reisfeld. (2010) Rapid estimation of activation enthalpies for cytochrome‐P450‐mediated hydroxylations. Journal of Computational Chemistry 32:4, pages 639-657.
Crossref
Crossref
Poongavanam Vasanthanathan, Jeroen Lastdrager, Chris Oostenbrink, Jan N. M. Commandeur, Nico P. E. Vermeulen, Flemming S. Jørgensen & Lars Olsen. (2011) Identification of CYP1A2 ligands by structure-based and ligand-based virtual screening. MedChemComm 2:9, pages 853.
Crossref
Crossref
Lars Carlsson, Ola Spjuth, Samuel Adams, Robert C Glen & Scott Boyer. (2010) Use of historic metabolic biotransformation data as a means of anticipating metabolic sites using MetaPrint2D and Bioclipse. BMC Bioinformatics 11:1.
Crossref
Crossref
Britta Bonn, Carina Leandersson, Fabien Fontaine & Ismael Zamora. (2010)
Enhanced metabolite identification with MS
E
and a semi-automated software for structural elucidation
. Rapid Communications in Mass Spectrometry 24:21, pages 3127-3138.
Crossref
Crossref
Guosheng Wu, Sarvesh C. Vashishtha & John C. L. Erve. (2010)
Characterization of Glutathione Conjugates of Duloxetine by Mass Spectrometry and Evaluation of
in Silico
Approaches to Rationalize the Site of Conjugation for Thiophene Containing Drugs
. Chemical Research in Toxicology 23:8, pages 1393-1404.
Crossref
Crossref
Poongavanam Vasanthanathan, Lars Olsen, Flemming Steen Jørgensen, Nico P. E. Vermeulen & Chris Oostenbrink. (2010) Computational Prediction of Binding Affinity for CYP1A2-Ligand Complexes Using Empirical Free Energy Calculations. Drug Metabolism and Disposition 38:8, pages 1347-1354.
Crossref
Crossref
Patrik Rydberg, David E. Gloriam, Jed Zaretzki, Curt Breneman & Lars Olsen. (2010) SMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism. ACS Medicinal Chemistry Letters 1:3, pages 96-100.
Crossref
Crossref
Paul R. Ortiz de Montellano. (2009) Hydrocarbon Hydroxylation by Cytochrome P450 Enzymes. Chemical Reviews 110:2, pages 932-948.
Crossref
Crossref
Sason Shaik, Shimrit Cohen, Yong Wang, Hui Chen, Devesh Kumar & Walter Thiel. (2009) P450 Enzymes: Their Structure, Reactivity, and Selectivity—Modeled by QM/MM Calculations. Chemical Reviews 110:2, pages 949-1017.
Crossref
Crossref
Judith C. Madden. 2010. Recent Advances in QSAR Studies. Recent Advances in QSAR Studies
283
304
.
Patrik Rydberg, Poongavanam Vasanthanathan, Chris Oostenbrink & Lars Olsen. (2009) Fast Prediction of Cytochrome P450 Mediated Drug Metabolism. ChemMedChem 4:12, pages 2070-2079.
Crossref
Crossref
F. Peter Guengerich. (2009) Cataloging the Repertoire of Nature's Blowtorch, P450. Chemistry & Biology 16:12, pages 1215-1216.
Crossref
Crossref
Scott Boyer. (2009) The Use of Computer Models in Pharmaceutical Safety Evaluation. Alternatives to Laboratory Animals 37:5, pages 467-475.
Crossref
Crossref
Justas Dapkunas, Andrius Sazonovas & Pranas Japertas. (2009) Probabilistic Prediction of the Human CYP3A4 and CYP2D6 Metabolism Sites. Chemistry & Biodiversity 6:11, pages 2101-2106.
Crossref
Crossref
Peteris Prusis & Lovisa Afzelius. (2009) Reduced vdW Radius Improves Site of Metabolism Predictions Using X‐Ray Structure of CYP2D6. QSAR & Combinatorial Science 28:8, pages 891-894.
Crossref
Crossref
Peteris Prusis & Lovisa Afzelius. (2009) Improvement of Site of Metabolism Predictions for CYP3A4 by Using Discriminant Analysis of Compound Preference of CYP3A4 X‐Ray Structural Conformers and Subsequent Docking. QSAR & Combinatorial Science 28:8, pages 865-868.
Crossref
Crossref
J Zaretzki, C Bergeron, K Bennett & C Breneman. (2009) A novel method for predicting ligand regioselectivity to metabolism by the CYP3A4 enzyme. Chemistry Central Journal 3:S1.
Crossref
Crossref
Mingyue Zheng, Xiaomin Luo, Qiancheng Shen, Yong Wang, Yun Du, Weiliang Zhu & Hualiang Jiang. (2009) Site of metabolism prediction for six biotransformations mediated by cytochromes P450. Bioinformatics 25:10, pages 1251-1258.
Crossref
Crossref
James Smith & Viktor Stein. (2009) SPORCalc: A development of a database analysis that provides putative metabolic enzyme reactions for ligand-based drug design. Computational Biology and Chemistry 33:2, pages 149-159.
Crossref
Crossref
Poongavanam Vasanthanathan, Jozef Hritz, Olivier Taboureau, Lars Olsen, Flemming Steen Jørgensen, Nico P. E. Vermeulen & Chris Oostenbrink. (2008) Virtual Screening and Prediction of Site of Metabolism for Cytochrome P450 1A2 Ligands. Journal of Chemical Information and Modeling 49:1, pages 43-52.
Crossref
Crossref
Gabriele Cruciani, Yasmin Aristei, Laura Goracci & Emanuele Carosati. 2009. From Molecules to Medicines. From Molecules to Medicines
63
77
.
Patrik Rydberg, Ulf Ryde & Lars Olsen. (2008) Prediction of Activation Energies for Aromatic Oxidation by Cytochrome P450. The Journal of Physical Chemistry A 112:50, pages 13058-13065.
Crossref
Crossref
Jozef Hritz, Anita de Ruiter & Chris Oostenbrink. (2008) Impact of Plasticity and Flexibility on Docking Results for Cytochrome P450 2D6: A Combined Approach of Molecular Dynamics and Ligand Docking. Journal of Medicinal Chemistry 51:23, pages 7469-7477.
Crossref
Crossref
Britta Bonn, Collen M. Masimirembwa, Yasmin Aristei & Ismael Zamora. (2008)
The Molecular Basis of CYP2D6-Mediated
N
-Dealkylation: Balance between Metabolic Clearance Routes and Enzyme Inhibition
. Drug Metabolism and Disposition 36:11, pages 2199-2210.
Crossref
Crossref
Emre M. Isin & F. Peter Guengerich. (2008) Substrate binding to cytochromes P450. Analytical and Bioanalytical Chemistry 392:6, pages 1019-1030.
Crossref
Crossref
Chandra Prakash & Alfin D. N. Vaz. 2008. Nuclear Receptors in Drug Metabolism. Nuclear Receptors in Drug Metabolism
1
41
.
David J. Livingstone & Han van de Waterbeemd. 2008. Drug Bioavailability. Drug Bioavailability
433
451
.
Patrik Rydberg, Ulf Ryde & Lars Olsen. (2008) Sulfoxide, Sulfur, and Nitrogen Oxidation and Dealkylation by Cytochrome P450. Journal of Chemical Theory and Computation 4:8, pages 1369-1377.
Crossref
Crossref
Tadhg P. BegleyHonglin Li, Mingyue Zheng, Xiaomin Luo, Weiliang Zhu & Hualiang Jiang. 2007. Wiley Encyclopedia of Chemical Biology. Wiley Encyclopedia of Chemical Biology
1
9
.
Patrik Rydberg, Sine Myrup Hansen, Jacob Kongsted, Per-Ola Norrby, Lars Olsen & Ulf Ryde. (2008) Transition-State Docking of Flunitrazepam and Progesterone in Cytochrome P450. Journal of Chemical Theory and Computation 4:4, pages 673-681.
Crossref
Crossref
Ismael Zamora. 2008. Antitargets. Antitargets
247
265
.